Developing Pharmacy Practice - FIP
Laboratories and Medicines Control Services Section of FIP, The Hague, The Netherlands Ms Agathe Wehrli, Secretary of Pharmacy Information Section, FIP, Switzerland Dr Albert Wertheimer, Center for Pharmaceutical Health Services Research, School of Pharmacy, Temple University, Philadelphia, USA, and President of the Administrative
Download Developing Pharmacy Practice - FIP
Information
Domain:
Source:
Link to this page:
Documents from same domain
FIP Education Initiatives
www.fip.orgThe Global Competency Framework (GbCF) v1 contains a core set of behavioural competencies synthesised from the above documents that should be generally …
Interview Skills - FIP
www.fip.orgSome Interview Questions You can expect to be asked some of the following types of questions in an interview. Case Questions are often used by consulting companies to assess analytical and problem solving skills. The interviewer presents a situation and asks you to discuss possible solutions. A sample case question is, "Describe a managed care ...
Related documents
Laboratory biosecurity guidance - WHO
www.who.intresearch, and pharmaceutical developments: all of these activities are carried out in biological laboratories in the private or public sectors. Biological materials are handled worldwide in laboratories for numerous genuine, justifiable and legitimate purposes, where small and large volumes of live microorganisms are replicated, where cellular
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euQ8(R2) Part II), Quality Risk Management (ICH Q9), and Pharmaceutical Quality Systems (ICH Q10). GMP principles as described in ICH Q7 should be applied regardless which approach is taken in pharmaceutical development and manufacturing.
ICH HARMONISED TRIPARTITE GUIDELINE
database.ich.orgGOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS ICH Harmonised Tripartite Guideline Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting on 10 November 2000, this guideline is recommended for adoption to the three regulatory parties to ICH